Sleep for Health & Longevity - Quick Reference Sheet

Sleep for Health & Longevity

Created on 07/13/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 4.8 Audit

Sleep is a foundational daily process supporting repair, metabolism, memory, immune function, and mood. Both too little and too much track with higher risk of death, heart disease, diabetes, and cognitive decline, with lowest risk around seven hours of regular, good-quality sleep. Protecting adequate, consistent, restorative sleep is a high-value, low-cost longevity pillar. (Full Review)

Protocol

Duration
7–9 hours
Sleep opportunity per night, adjusted to stable daytime alertness without an alarm-driven deficit
Wake Time
Fixed daily
Same wake time every day including weekends; bedtime follows natural sleepiness
Light
Morning & evening
10–30 min outdoor light within an hour of waking; dim indoor and screen light 2–3 hours before bed
Time to effect
Metabolic & Cognitive
Weeks–months
Metabolic, cardiovascular, and cognitive benefits accrue over weeks to months of consistent adequate sleep
Alertness & Mood
One night
Alertness and mood often improve after a single good night
Sleep Debt
>1 weekend
Recovering from chronic sleep debt typically takes more than one weekend

Benefits

Contraindications
  • Bipolar disorder
  • Untreated moderate-to-severe obstructive sleep apnea
  • Certain seizure disorders
Key Interactions
  • Beta-blockers (propranolol, metoprolol)
  • Corticosteroids (prednisone), stimulants (methylphenidate, amphetamines)
  • Antidepressants (SSRIs such as fluoxetine)
  • Decongestants (pseudoephedrine), caffeine-containing analgesics
  • Sedating antihistamines (diphenhydramine)
  • Melatonin, valerian with sleep medications and alcohol
  • Alcohol, cannabis/THC, prescription sedatives
  • High-dose caffeine, evening pre-workout supplements
  • Evening bright light and screens
  • Shift work, jet lag
  • Intense exercise within 1–2 hours of bedtime

Risk & Side Effects

  • High: Excessive sleep duration associated with poor outcomes
  • Medium: Dependence on sedative-hypnotic sleep medications; masking of undiagnosed sleep disorders
  • Low: Sleep inertia from long or poorly timed naps; orthosomnia
  • Speculative: Long-term safety uncertainty of chronic exogenous melatonin

Monitoring

Marker Target Why
Sleep duration (actigraphy/wearable) 7–9 h/night Core exposure linked to longevity
Sleep efficiency >85% Time asleep vs. time in bed; flags fragmentation
Blood pressure (incl. nocturnal dip) <120/80 mmHg; >10% nighttime dip Sleep supports healthy nighttime BP fall
Fasting glucose 70–90 mg/dL Short sleep worsens glucose control
HbA1c <5.4% Reflects average blood sugar over ~3 months
hs-CRP <1.0 mg/L Tracks sleep-related inflammation
Resting heart rate / HRV Lower resting HR; higher HRV for the individual Reflects recovery and autonomic balance
Apnea-Hypopnea Index (AHI) <5 events/h Detects obstructive sleep apnea
Ferritin (if restless legs suspected) 50–75+ ng/mL Low iron stores worsen restless legs

Cadence: Baseline 1–2 week sleep log or wearable record plus cardiometabolic labs; reassess at 4–8 weeks after establishing new habits, then every 6–12 months (or sooner if a sleep disorder is suspected)

Qualitative Assessment

  • Daytime alertness without reliance on caffeine
  • Sleep-onset latency of roughly 15–20 minutes
  • Morning refreshment and stable energy across the day
  • Mood stability and reduced irritability
  • Cognitive clarity, focus, and memory